Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
Year: 2010
Type: article
Source: Clinical Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2127283584
